COMMUNIQUÉS West-GlobeNewswire

-
K2M Group Holdings, Inc. to Participate in Two Investor Conferences in September
27/08/2018 -
Editas Medicine Announces Transition of Chief Medical Officer
27/08/2018 -
Wright Medical Group N.V. Announces Proposed Public Offering of Ordinary Shares
27/08/2018 -
Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Europe for the Treatment of Mucopolysaccharidosis VII
27/08/2018 -
National Brain Tumor Society Statement on Passing of Sen. John McCain
27/08/2018 -
La Costa Glen Retirement Community Named Great Place to Work
27/08/2018 -
Biosenta Announces Signing Exclusive Global Royalty Agreement
27/08/2018 -
Cognoa Demonstrates Advances of its AI-Based Technology for Identifying Autism in Children
27/08/2018 -
NeuroMetrix to Present at H.C.Wainwright & Co 20th Annual Global Investment Conference in New York City
27/08/2018 -
DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company
27/08/2018 -
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
27/08/2018 -
Vitalhub Reports Second Straight Quarter of Positive Adjusted EBITDA
27/08/2018 -
Landmarks Around the World to “Go Teal” on November 8th for AFA’s “Light the World in Teal” Alzheimer’s Awareness Campaign
27/08/2018 -
Adamis Pharmaceuticals Provides Business Update
27/08/2018 -
Ossur Hf : Transactions in relation to share buyback program
27/08/2018 -
Sanofi : Disclosure of trading in own shares
27/08/2018 -
Sanofi : Déclaration des transactions sur actions propres
27/08/2018 -
CORRECTING and REPLACING -- Tetraphase Pharmaceuticals to Participate at Upcoming Investor Conference
27/08/2018 -
MPI - FDA approves OVs IDE and IND for ovarian cancer with its PARP inhibitor and DRP
27/08/2018
Pages